The American pharmaceutical corporation Rafarma Pharmaceuticals, Inc. announced the creation of a joint venture with the Agency for the Development of the Pharmaceutical Industry under the Ministry of Health of the Republic of Uzbekistan.
The Agency for the Development of the Pharmaceutical Industry will obtain the necessary registration and certification for all future medicines produced in the partnership. Rafarma provides experts in the relevant fields, supervises construction and supplies the necessary equipment.
To implement the project, it is planned to purchase a land plot – 10 hectares in the created innovative scientific and production pharmaceutical cluster “Tashkent Pharmaceutical Park” and build a plant on its territory. The projected costs are currently $ 82,000,000.
Currently, the parties plan to start developing a schedule for the implementation and launch of the project (projected schedule for 2021-2025).
Другие новости и события
Any use (reproduction, publication, copying, reprinting, distribution, translation, broadcasting, processing and other methods of distribution) of the materials of the Investment Portal - Invest.gov.uz, without indicating the original source and a link to the Portal is strictly prohibited!